April 29 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday published the final rule to ensure safety and effectiveness of laboratory developed tests (LDTs), which are designed, manufactured and used within a clinical laboratory. (Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini Ganguli)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205.2 USD | -1.03% | +2.69% | -9.70% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
205.2 USD | -1.03% | +2.69% | 17.3B | ||
139 USD | +0.55% | +0.81% | 15.44B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.70% | 17.3B | |
+25.21% | 88.77B | |
-22.28% | 77.04B | |
+3.24% | 26.87B | |
0.00% | 16.89B | |
+0.78% | 15.44B | |
+77.65% | 13.11B | |
+70.99% | 13.15B | |
-23.68% | 13.16B | |
+24.05% | 12.66B |
- Stock Market
- Equities
- LH Stock
- News Labcorp Holdings Inc.
- US FDA publishes final rule for laboratory developed tests